The global In Vitro Diagnostics quality control market size was valued at USD 905 million in 2018 and is anticipated to register a CAGR of 4.1% and the global IVD infectious diseases market size was valued at USD 18.8 billion in 2018 which is likely to exhibit a CAGR of 6.7% from 2018 to 2026. IVDD to IVDR transition requires Regulatory bodies to strictly monitor quality control and regular quality check of IVD devices and service providers. The new regulation also introduces vigilance. Thus, even after its certification a product must be validated within regular intervals to ensure its quality.
Covering the preliminary stages in the 1st Annual European IVD Quality Control and Infectious Diseases Conference, the second edition is back to address, discuss and train the industry executives with latest challenges, solutions and techniques in establishing and developing quality management procedures, quality controls by type, by application, quality assurance, data management, technology, regular testing of quality management procedures etc. It’s an unmissable opportunity for the attendees to interact with the prominent minds in the field of Infectious Diseases and learn from interactive sessions with the broadly acclaimed speakers across Europe